IL Chicago의 겸형 적혈구증 임상 시험
겸형 적혈구증 관련 연구 18개가 Chicago 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
피험자 모집 중1상
- University of Illinois at Chicago College of Medicine, Chicago
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
피험자 모집 중3상
- Uni of Illinois Hospital and HSC, Chicago
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
피험자 모집 중1상
- University of Illinois Hospital and Health Sciences System, Chicago
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
피험자 모집 중3상
- Univer Of Illinois at Chicago, Chicago
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
피험자 모집 중3상
- Childrens Hospital of Chicago, Chicago
- Univer Of Illinois at Chicago, Chicago
Tocilizumab for Acute Chest Syndrome
피험자 모집 중2상
- University of Chicago, Chicago
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
피험자 모집 중1/2상건강한 지원자 환영
- Local Institution - 0034, Chicago
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
피험자 모집 중2/3상
- University of Illinois at Chicago Clinical Research Center, Chicago
- University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
피험자 모집 중관찰 연구
- Rush University Medical Center, Chicago
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
피험자 모집 중2상
- University of Illinois at Chicago, Chicago
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
피험자 모집 중3상
- University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
피험자 모집 중2상
- University of Illinois at Chicago, Chicago
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
피험자 모집 중관찰 연구
- Comer Children's Hospital (MRD-HCT), Chicago
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
피험자 모집 중2상
- University of Illinois Chicago, Sickle Cell Center, Chicago
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
피험자 모집 중
- University of Illinois at Chicago, Chicago
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
피험자 모집 중2상
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
피험자 모집 중
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
피험자 모집 중관찰 연구
- University of Illinois, Chicago
다른 도시의 겸형 적혈구증 시험
- Atlanta, GA연구 22개
- Washington, DC연구 20개
- Memphis, TN연구 18개
- Philadelphia, PA연구 15개
- Birmingham, AL연구 14개
- New York City, NY연구 13개
- St. Louis, MO연구 12개
- Durham, NC연구 10개
- Cincinnati, OH연구 10개
- Houston, TX연구 10개
- Boston, MA연구 10개
- Pittsburgh, PA연구 9개
Chicago의 다른 연구
- 비소세포폐암연구 61개
- 유방암연구 58개
- 암 (전체)연구 51개
- 전이성 암연구 45개
- 전립선암연구 45개
- 비만연구 41개
- 폐암연구 41개
- 난소암연구 36개
- 뇌졸중연구 34개
- 대장직장암연구 33개
- 심부전연구 31개
- 과체중연구 28개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.